El Mundo on MSN22h
US approves a new painkiller with less risk of addiction than opioids and equally potentThe suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
HealthDay News — Distribution of prescribed opioid analgesics is lower in majority non-White versus majority White communities across all levels of socioeconomic deprivation, according to a study ...
The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
Find out what support is available from a GP when a person has dementia, including the role of the GP in dementia care. The GP can support a person even if they don't accept their diagnosis. General ...
The leaders of Mexico and Canada each said they had struck agreements to pause tariffs for 30 days, but levies on products ...
Atlanta’s chapter of the Party for Socialism and Liberation, or PSL, held an organizing meeting at the Little Five Points ...
ABC 10News anchors Moses Small and Aaron Dickens break down 2025's Groundhog Day predictions Chesley "Sully" Sullenberger, ...
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...
Daily Voice on MSN12d
Non-Opioid Pain Medication Journavx Gets FDA ApprovalThe Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
low levels of physical activity or spending a lot of time sitting down, or high blood lipids such as cholesterol, or high blood pressure. Dr Khan said there are currently no approved medications ...
One of the main hurdles preventing the pharma industry from solving this problem is that pain-management medication is still vitally important. Paul Howe, chief commercial officer at Protega Pharma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback